ArticleBMC public health2025
Study on the prediction performance of AIDS monthly incidence in Xinjiang based on time series and deep learning models.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Large language models as versatile predictive engines for notifiable infectious diseases.PLOS digital health · 2026Article
- Forecasting monthly hepatitis B cases in China: a nationwide comparative study based on surveillance data.BMC public health · 2026Article
- Forecasting monthly AIDS incidence in China via LSTM-CNN parallel fusion: a comparative study of 10 predictive models.Frontiers in public health · 2026Article
- Study on the spatial-temporal evolution and influencing factors of AIDS incidence in China from 2006 to 2022.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveAIDS is a highly fatal infectious disease of Class B, and Xinjiang is a high-incidence region for AIDS in China. The core of prevention and control lies in early monitoring and early warning. This study aims to identify the best model for predicting the monthly AIDS incidence in Xinjiang, providing scientific evidence for AIDS prevention and control.
methodsMonthly AIDS incidence data from January 2004 to December 2020 in Xinjiang were collected. Six different models, including the ARIMA (2,1,2) model, ARIMA (2,1,2)-EGARCH (2,2) combined model, ARIMA (2,1,2)-TGARCH (1,1) combined model, ETS (A, A, A) model, XGBoost model, and LSTM model, were used for fitting and forecasting.
resultsAll models were able to capture the overall trend of the monthly AIDS incidence in Xinjiang. In terms of RMSE and MAE, the ETS (A, A, A) model performed the best, achieving the smallest values. For the MAPE metric, the ARIMA (2,1,2)-TGARCH (1,1) model performed the best. Considering RMSE, MAE, and MAPE together, the ETS (A, A, A) model was the best-performing model in this study. The LSTM model also showed good predictive performance, while the XGBoost model and ARIMA (2,1,2) model performed relatively poorly.
conclusionThe ETS (A, A, A) model is the best model for predicting the monthly AIDS incidence in Xinjiang. Deep learning models (such as LSTM) have significant potential in time series forecasting. The XGBoost model and ARIMA (2,1,2) model may have limitations when handling time series data, and future improvements or combinations could enhance prediction performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.